Early events pre-initiation of alphaherpes viral gene expression

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

Volumn , Issue , 2007, Pages 112-127

  Kristie, Thomas M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 52649115135     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545313.009     Document Type: Chapter

References (116)

1. Adams, J., Kelso, R., and Cooley, L. (2000). The kelch repeat super-family of proteins: Propellers of cell function. Trends Cell Biol., 10, 17-24.
2. Ajuh, P. M., Browne, G. J., Hawkes, N. A., Cohen, P. T., Roberts, S. G., and Lamond, A. I. (2000). Association of a protein phosphatase 1 activity with the human factor C1 (HCF) complex. Nucl. Acids Res., 28, 678-686.
3. Ajuh, P., Chusainow, J., Ryder, U., and Lamond, A. I. (2002). A novel function for human factor C1 (HCF-1), a host protein required for herpes simplex virus infection, in pre-mRNA splic-ing. EMBO J., 21, 6590-6602.
4. Aurrekoetxea-Hernandez, K., and Buetti, E. (2000). Synergistic action of GA-binding protein and glucocorticoid receptor in transcription from the mouse mammary tumor virus pro-moter. J. Virol., 74, 4988-4998.
5. Babb, R., Cleary, M. A., and Herr, W. (1997). OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain. Mol. Cell Biol., 17, 7295-7305.
6. Babb, R., Huang, C. C., Aufiero, D. J., and Herr, W. (2001). DNA recognition by the herpes simplex virus transactivator VP16: A novel DNA-binding structure. Mol. Cell Biol., 21, 4700-4712.
7. Bannert, N., Avots, A., Baier, M., Serfling, E., and Kurth, R. (1999). GA-binding protein factors, in concert with the coactivator CREB binding protein/p300, control the induction of the inter-leukin 16 promoter in T lymphocytes. Proc. Natl Acad. Sci. USA, 96, 1541-1546.
8. Black, A. R., Black, J. D., and Azizkhan-Clifford, J. (2001). Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell Physiol., 188, 143-160.
9. Boulon, S., Dantonel, J. C., Binet, V. et al. (2002). Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB-and CREB binding protein-independent mechanism. Mol. Cell Biol., 22, 7769-7779.
10. Brownlees, J., Gough, G., Thomas, S. et al. (1999). Distinct responses of the herpes simplex virus and varicella zoster virus immedi-ate early promoters to the cellular transcription factors Brn-3a and Brn-3b. Int. J. Biochem. Cell Biol., 31, 451-461.
11. Chasman, D., Cepek, K., Sharp, P. A., and Pabo, C. O. (1999). Crystal structure of an OCA-B peptide bound to an Oct-1 POU domain/octamer DNA complex: Specific recognition of a protein-DNA interface. Genes Dev., 13, 2650-2657.
12. Clerc, R. G., Corcoran, L. M., LeBowitz, J. H., Baltimore, D., and Sharp, P. A. (1988). The B-cell-specific Oct-2 protein contains POU box-and homeo box-type domains. Genes Dev., 2, 1570-1581.
13. Coenjaerts, F. E., van Oosterhout, J. A., and van der Vliet, P. C. (1994). The Oct-1 POU domain stimulates adenovirus DNA replica-tion by a direct interaction between the viral precursor ter-minal protein-DNA polymerase complex and the POU home-odomain. EMBO J., 13, 5401-5409.
14. Cosma, M. P. (2002). Ordered recruitment: Gene-specific mecha-nism of transcription activation. Mol. Cell, 10, 227-236.
15. De Jong, R. N., Mysiak, M. E., Meijer, L. A., van der Linden, M., and van der Vliet, P. C. (2002). Recruitment of the priming protein pTP and DNA binding occur by overlapping Oct-1 POU home-odomain surfaces. EMBO J., 21, 725-735.
16. De la Brousse, F. C., Birkenmeier, E. H., King, D. S., Rowe, L. B., and McKnight, S. L. (1994). Molecular and genetic characterization of GABP beta. Genes Dev., 8, 1853-1865.
17. Flory, E., Hoffmeyer, A., Smola, U., Rapp, U. R., and Bruder, J. T. (1996). Raf-1 kinase targets GA-binding protein in transcrip-tional regulation of the human immunodeficiency virus type 1 promoter. J. Virol., 70, 2260-2268.
18. Freiman, R. N. and Herr, W. (1997). Viral mimicry: Common mode of association with HCF by VP16 and the cellular protein LZIP. Genes Dev., 11, 3122-3127.
19. Fromm, L. and Burden, S. J. (1998). Synapse-specific and neuregulin-induced transcription require an ets site that binds GABPalpha/GABPbeta. Genes Dev., 12, 3074-3083.
20. Gold, M. O., Tassan, J. P., Nigg, E. A., Rice, A. P., and Herrmann, C. H. (1996). Viral transactivators E1A and VP16 interact with a large complex that is associated with CTD kinase activity and con-tains CDK8. Nucl. Acids Res., 24, 3771-3777.
21. Gonzalez, M. I. and Robins, D. M. (2001). Oct-1 preferentially inter-acts with androgen receptor ina DNA-dependent manner that facilitates recruitment of SRC-1. J. Biol. Chem., 276, 6420-6428.
22. Goto, H., Motomura, S., Wilson, A. C. et al. (1997). A single-point mutation in HCF causes temperature-sensitive cell-cycle arrest and disrupts VP16 function. Genes Dev., 11, 726-737.
23. Grenfell, S. J., Latchman, D. S., and Thomas, N. S. (1996). Oct-1 [corrected] and Oct-2 DNA-binding site specificity is regulated in vitro by different kinases. Biochem J., 315(3), 889-893.
24. Gugneja, S., Virbasius, J. V., and Scarpulla, R. C. (1995). Four struc-turally distinct, non-DNA-binding subunits of human nuclear respiratory factor 2 share a conserved transcriptional activa-tion domain. Mol. Cell Biol., 15, 102-111.
25. Gugneja, S., Virbasius, C. M., and Scarpulla, R. C. (1996). Nuclear respiratory factors1 and 2 utilize similar glutamine-containing clusters ofhydrophobic residues to activate transcription. Mol. Cell Biol., 16, 5708-5716.
26. Gunther, M., Laithier, M., and Brison, O. (2000). A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening. Mol. Cell Biochem., 210, 131-142.
27. Hall, D. B. and Struhl, K. (2002). The VP16 activation domain inter-acts with multiple transcriptional components as determined by protein-protein cross-linking in vivo. J. Biol. Chem., 277, 46043-46050.
28. Herrera, F. J. and Triezenberg, S. J. (2004). VP16-dependent asso-ciation of chromatin-modifying coactivators and underrp-resentation of histones at immediate-early gene promoters during herpes simplex virus infection. J. Virol., 78(18), 9689-9696.
29. Herrmann, C. H., Gold, M. O., and Rice, A. P. (1996). Viral trans-activators specifically target distinct cellular protein kinases that phosphorylate the RNApolymerase II C-terminal domain. Nucl. Acids Res., 24, 501-508.
30. Hoffmeyer, A., Avots, A., Flory, E., Weber, C. K., Serfiing, E., and Rapp, U. R. (1998). The GABP-responsive element of the interleukin-2 enhancer is regulated by JNK/SAPK-activating pathways in T lymphocytes. J. Biol. Chem., 273, 10112-10119.
31. Hovde, S., Hinkley, C. S., Strong, K. et al. (2002). Activator re-cruitment by the general transcription machinery: X-ray structural analysis of the Oct-1 POU domain/human U1 octamer/SNAP190 peptide ternary complex. Genes Dev., 16, 2772-2777.
32. Hughes, T. A., La Boissiere, S., and O'Hare, P. (1999). Analysis of functional domains of the host cell factor involved in VP16 complex formation. J. Biol. Chem., 274, 16437-16443.
33. Inamoto, S., Segil, N., Pan, Z. Q., Kimura, M., and Roeder, R. G. (1997). The cyclin-dependent kinase-activating kinase (CAK) assembly factor, MAT1, targets and enhances CAK activity on the POU domains of octamer transcription factors. J. Biol. Chem., 272, 29852-29858.
34. Jin, S., Fan, F., Fan, W. et al. (2001). Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage. Oncogene, 20, 2683-2690.
35. Johnson, K. M., Mahajan, S. S., and Wilson, A. C. (1999). Her-pes simplex virus transactivator VP16 discriminates between HCF-1 and a novel family member, HCF-2. J. Virol., 73, 3930-3940.
36. Jones, K. A. and Tjian, R. (1985). Sp1 binds to promoter sequences and activates herpes simplex virus ‘immediate-early’ gene transcription in vitro. Nature, 317, 179-182.
37. Julien, E. and Herr, W. (2003). Proteolytic processing is necessary to separate and ensure proper cell growth and cytokinesis func-tions of HCF-1. Embo J., 22, 2360-2369.
38. Kaczynski, J., Cook, T., and Urrutia, R. (2003). Sp1-and Kruppel-like transcription factors. Genome Biol., 4, 206.
39. Khurana, B. and Kristie, T. M. (2004). A protein sequestering sys-tem reveals control of cellular programs by the transcrip-tional coactivator HCF-1. J. Biol. Chem., 279(32), 33673-33683.
40. Kim, D. B. and DeLuca, N. A. (2002). Phosphorylation of transcrip-tion factor Sp1 during herpes simplex virus type1 infection. J. Virol., 76, 6473-6479.
41. Kinchington, P. R., Hougland, J. K., Arvin, A. M., Ruyechan, W. T., and Hay, J. (1992). The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles. J. Virol., 66, 359-366.
42. Klemm, J. D., Rould, M. A., Aurora, R., Herr, W., and Pabo, C. O. (1994). Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell, 77, 21-32.
43. Knez, J., Piluso, D. et al. (2006). Host cell factor-1 and E2F4 intract via multiple determinants in each protein. Mol. Cell Biochem.Apr 22; [Epub ahead of print].
44. Kristie, T. M. and Sharp, P. A. (1990). Interactions of the Oct-1 POU subdomains with specific DNA sequences and with the HSV alpha-trans-activator protein. Genes Dev., 4, 2383-2396.
45. Kristie, T. M. and Sharp, P. A. (1993). Purification of the cellular C1 factor required for the stable recognition of the Oct-1 home-odomain by the herpes simplex virus alpha-trans-induction factor (VP16). J. Biol. Chem., 268, 6525-6534.
46. Kristie, T. M., LeBowitz, J. H., and Sharp, P. A. (1989). The octamer-binding proteins form multi-protein-DNA complexes with the HSV alpha TIF regulatory protein. Embo J., 8, 4229-4238.
47. Kristie, T. M., Pomerantz, J. L., Twomey, T. C., Parent, S. A., and Sharp, P. A. (1995). The cellular C1 factor of the herpes simplex virus enhancer complex is a family of polypeptides. J. Biol. Chem., 270, 4387-4394.
48. Kristie, T. M., Vogel, J. L., and Sears, A. E. (1999). Nuclear localization of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency. Proc. Natl Acad. Sci. USA, 96, 1229-1233.
49. Krumm, A., Hickey, L. B., and Groudine, M. (1995). Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation. Genes Dev., 9, 559-572.
50. La Boissiere, S., Walker, S., and O‘Hare, P. (1997). Concerted activity of host cell factor subregions in promoting stable VP16 com-plex assembly and preventing interference by the acidic acti-vation domain. Mol. Cell Biol., 17, 7108-7118.
51. La Boissiere, S., Hughes, T., and O'Hare, P. (1999). HCF-dependent nuclear import of VP16. EMBO J., 18, 480-489.
52. Lai, J. S. and Herr, W. (1997). Interdigitated residues within a small region of VP16 interact with Oct-1, HCF, and DNA. Mol. Cell Biol., 17, 3937-3946.
53. Lai, J. S., Cleary, M. A., and Herr, W. (1992). A single amino acid exchange transfers VP16-induced positive control from the Oct-1 to the Oct-2 homeo domain. Genes Dev., 6, 2058-2065.
54. LaMarco, K., Thompson, C. C., Byers, B. P., Walton, E. M., and McK-night, S. L. (1991). Identification of Ets-and notch-related sub-units in GA binding protein. Science, 253, 789-792.
55. Latchman, D. S. (1996). The Oct-2 transcription factor. Int. J. Biochem. Cell Biol., 28, 1081-1083.
56. Latchman, D. S. (1999). POU family transcription factors in the nervous system. J. Cell Physiol., 179, 126-133.
57. Lillycrop, K. A., Dawson, S. J., Estridge, J. K., Gerster, T., Matthias, P., and Latchman, D. S. (1994). Repression of a herpes simplex virus immediate-early promoter by the Oct-2 transcription factor is dependent on an inhibitory region at the N terminus of the protein. Mol. Cell Biol., 14, 7633-7642.
58. Lin, J., Puigserver, P., Donovan, J., Tarr, P., and Spiegelman, B. M. (2002). Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta), a novel PGC-1-related tran-scription coactivator associated with host cell factor. J. Biol. Chem., 277, 1645-1648.
59. Liu, Y., Gong, W., Huang, C. C., Herr, W., and Cheng, X.(1999). Crystal structure of the conserved core of the herpes simplex virus transcriptional regulatory protein VP16. Genes Dev., 13, 1692-1703.
60. Lu, R. and Misra, V. (2000a). Potential role for luman, the cel-lular homologue of herpes simplex virus VP16 (alpha gene trans-inducing factor), in herpesvirus latency. J. Virol., 74, 934-943.
61. Lu, R. and Misra, V. (2000b). Zhangfei: A second cellular protein interacts with herpes simplex virus accessory factor HCF in a manner similar to Luman and VP16. Nucl. Acids Res., 28, 2446-2454.
62. Lu, R., Yang, P., O‘Hare, P., and Misra, V. (1997). Luman, a new mem-ber of the CREB/ATF family, binds to herpes simplex virus VP16-associated host cellular factor. Mol. Cell Biol., 17, 5117-5126.
63. Lu, R., Yang, P., Padmakumar, S., and Misra, V. (1998). The her-pesvirus transactivator VP16 mimics a human basic domain leucine zipper protein, luman, in its interaction with HCF. J. Virol., 72, 6291-6297.
64. Luciano, R. L. and Wilson, A. C. (2002). An activation domain in the C-terminal subunit of HCF-1 is important for transactivation by VP16 and LZIP. Proc. Natl Acad. Sci. USA, 99, 13403-13408.
65. Luciano, R. L. and Wilson, A. C. (2003). HCF-1 function as a coacti-vator for the zincfinger protein Krox20. J. Biol. Chem., 278(51), 51116-51124.
66. Mahajan, S. S. and Wilson, A. C. (2000). Mutations in host cell factor 1 separate its role in cell proliferation from recruitment of VP16 and LZIP. Mol. Cell Biol., 20, 919-928.
67. Mahajan, S. S. Little, M. M., Vazquez, R., and Wilson, A. C. (2002). Interaction of HCF-1 with a cellular nuclear export factor. J. Biol. Chem., 277, 44292-44299.
68. McKee, T. A. and Preston, C. M. (1991). Identification of two protein bindingsites within the varicella-zoster virus major immediate early gene promoter. Virus Res., 20, 59-69.
69. Memedula, S. and Belmont, A. S. (2003). Sequential recruitment of HAT and SWI/SNF components to condensed chromatin by VP16. Curr. Biol., 13, 241-246.
70. Mittal, V., Ma, B., and Hernandez, N. (1999). SNAP(c):a core pro-moter factor with a built-in DNA-binding damper that is deactivated by the Oct-1 POU domain. Genes Dev., 13, 1807-1821.
71. Moriuchi, H., Moriuchi, M., and Cohen, J. I. (1995). Proteins and cis-acting elements associated with transactivation of the varicella-zoster virus (VZV) immediate-early gene 62 pro-moter by VZV open readingframe10 protein. J. Virol., 69,4693-4701.
72. Narayanan, A., Nogueira, M. L., and Kristie, T. M. (2005). Combina-torial transcription of herpes simplex virus and varicella zoster virus immediate early genes is strictly determined by the cel-lular co-activator HCF-1. J. Biol. Chem., 280, 1369-1375.
73. Nishikawa, J., Kokubo, T., Horikoshi, M., Roeder, R. G., and Nakatani, Y. (1997). Drosophila TAF(II)230 and the transcrip-tional activator VP16 bind competitively to the TATA box-binding domain of the TATA box-binding protein. Proc. Natl Acad. Sci. USA, 94, 85-90.
74. Nogueira, M. L., Wang, V. E. H., Tantin, D., Sharp, P. A., and Kristie, T. M. (2004). Herpes simplex virus infections are arrested in Oct-1 deficient cells. Proc. Natl Acad. Sci. USA, 101, 1473-1478.
75. O'Reilly, D., Hanscombe, O., and O'Hare, P. (1997). A single serine residue at position 375 of VP16 is critical for complex assem-bly with Oct-1 and HCF and is a target of phosphorylation by casein kinase II. Embo J., 16, 2420-2430.
76. Ouyang, L., Jacob, K. K., and Stanley, F. M. (1996). GABP mediates insulin-increased prolactin gene transcription. J. Biol. Chem., 271, 10425-10428.
77. Perera, L. P., Mosca, J. D., Sadeghi-Zadeh, M., Ruyechan, W. T., and Hay, J. (1992). The varicella-zoster virus immediate early pro-tein, IE62, can positively regulate its cognate promoter. Virol-ogy, 191, 346-354.
78. Phillips, K. and Luisi, B. (2000). The virtuoso of versatility: POU proteins that fiex to fit. J. Mol. Biol., 302, 1023-1039.
79. Piluso, D., Bilan, P., and Capone, J. P. (2002). Host cell factor-1 inter-acts with and antagonizes transactivation by the cell cycle reg-ulatory factor Miz-1. J. Biol. Chem., 277, 46799-46808.
80. Pomerantz, J. L., Kristie, T. M., and Sharp, P. A. (1992). Recognition of the surface of a homeo domain protein. Genes Dev., 6, 2047-2057.
81. Puigserver, P. and Spiegelman, B. M. (2003). Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): Transcriptional coactivator and metabolic reg-ulator. Endocr. Rev., 24, 78-90.
82. Regier, J. L., Shen, F., and Triezenberg, S. J. (1993). Pattern of aro-matic and hydrophobic amino acids critical for one of two subdomains of the VP16 transcriptional activator. Proc. Natl Acad. Sci. USA, 90, 883-887.
83. Roizman, B. and Sears, A. E.(1996). Herpes simplex viruses and their replication. In Fundamental Virology, ed. B. N. Fields, Knipe, D. M., and Howley, P. M., Philadelphia: Lippincott-Raven Pub-lishers: 1043-1107.
84. Ryu, H., Lee, J., Zaman, K. et al. (2003). Sp1 and Sp3 are oxida-tivestress-inducible, antideath transcription factors in cortical neurons. J. Neurosci., 23, 3597-3606.
85. Sawada, J., Simizu, N., Suzuki, F. et al. (1999). Synergistic transcrip-tional activation by hGABP and select members of the acti-vation transcription factor/cAMP response element-binding protein family. J. Biol. Chem., 274, 35475-35482.
86. Scarpulla, R. C. (2002). Nuclear activators and coactivators in mam-malian mitochondrial biogenesis. Biochim. Biophys. Acta., 1576, 1-14.
87. Scarr, R. B. and Sharp, P. A. (2002). PDCD2 is a negative regulator of HCF-1 (C1). Oncogene, 21, 5245-5254.
88. Scarr, R. B., Smith, M. R., Beddall, M., and Sharp, P. A. (2000). A novel 50-kilodalton fragment of host cell factor 1 (C1) in G(0) cells. Mol. Cell Biol., 20, 3568-3575.
89. Shen, F., Triezenberg, S. J., Hensley, P., Porter, D., and Knutson, J. R. (1996). Transcriptional activation domain of the herpesvirus protein VP16 becomes conformationally constrained upon interaction with basal transcription factors. J. Biol. Chem., 271, 4827-4837.
90. Simmen, K. A., Newell, A., Robinson, M. et al. (1997). Protein interactions in the herpes simplex virus type 1 VP16-induced complex: VP16 peptide inhibition and mutational analysis of host cell factor requirements. J. Virol., 71, 3886-3894.
91. Sturm, R. A., Das, G., and Herr, W. (1988). The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. Genes Dev., 2, 1582-1599.
92. Suske, G. (1999). The Sp-family of transcription factors. Gene, 238, 291-300.
93. Tanaka, M., Lai, J. S., and Herr, W. (1992). Promoter-selective activa-tion domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter. Cell, 68, 755-767.
94. Thompson, C. C., Brown, T. A., and McKnight, S. L. (1991). Con-vergence of Ets-and notch-related structural motifs in a het-eromeric DNA binding complex. Science, 253, 762-768.
95. Tiedt, R., Bartholdy, B. A., Matthias, G., Newell, J. W., and Matthias, P. (2001). The RING Finger protein Siah-1 regulates the level of the transcriptional coactivator OBF-1. EMBO J., 20, 4143-4152.
96. Triezenberg, S. J., LaMarco, K. L., and McKnight, S. L. (1988). Evidence of DNA: Protein interactions that mediate HSV-1 immediate early gene activation by VP16. Genes Dev., 2, 730-742.
97. Vignali, M., Steger, D. J., Neely, K. E., and Workman, J. L. (2000). Distribution of acetylated histones resulting from Gal4-VP16 recruitment of SAGA and NuA4 complexes. EMBO J., 19, 2629-2640.
98. Vogel, J. L. and Kristie, T. M. (2000a). Autocatalytic proteolysis of the transcription factor-coactivator C1 (HCF):a potential role for proteolytic regulation of coactivator function. Proc. Natl Acad. Sci. USA, 97, 9425-9430.
99. Vogel, J. L. and Kristie, T. M. (2000b). The novel coactivatorC1(HCF) coordinates multiprotein enhancer formation and mediates transcription activation by GABP. EMBO J., 19, 683-690.
100. Vogel, J. L. and Kristie, T. M. (2001). The C1 factor (HCF). In The Encyclopedia of Molecular Medicine, ed. T. E. Creighton, New York: John Wiley and Sons, Inc.: 732-735.
101. Vogel, J. L. and Kristie, T. M. (2006). Site-specific proteolysis of the transcriptional coactivator HCF-1 can regulate its interac-tion with protein cofactors. Proc. Natl Acad. Sci. USA, 103(18), 6817-6822.
102. Walker, S., Greaves, R., and O‘Hare, P. (1993). Transcriptional activa-tion by the acidic domain of Vmw65 requires the integrity of the domain and involves additional determinants distinct from those necessary for TFIIB binding. Mol. Cell Biol., 13, 5233-5244.
103. Wilson, A. C., LaMarco, K., Peterson, M. G., and Herr, W. (1993). The VP16 accessory protein HCF is a family of polypep-tides processed froma large precursor protein. Cell, 74, 115-125.
104. Wilson, A. C., Freiman, R. N., Goto, H., Nishimoto, T., and Herr, W. (1997). VP16 targets an amino-terminal domain of HCF involved in cell cycle progression. Mol. Cell Biol., 17, 6139-6146.
105. Wilson, A. C., Boutros, M., Johnson, K. M., and Herr, W. (2000). HCF-1 amino-and carboxy-terminal subunit association through two separate sets of interaction modules: Involvement of fibronectin type 3 repeats. Mol. Cell Biol., 20, 6721-6730.
106. Wu, T. J., Monokian, G., Mark, D. F., and Wobbe, C. R. (1994). Tran-scriptional activation by herpes simplex virus type 1 VP16 in vitro and its inhibition by oligopeptides. Mol. Cell Biol., 14, 3484-3493.
107. Wysocka, J. and Herr, W. (2003). The herpes simplex virus VP16-induced complex: The makings of a regulatory switch. Trends Biochem. Sci., 28, 294-304.
108. Wysocka, J., Reilly, P. T., and Herr, W. (2001). Loss of HCF-1-chromatin association precedes temperature-induced growth arrest of tsBN67 cells. Mol. Cell Biol., 21, 3820-3829.
109. Wysocka, J., Myers, M. P., Laherty, C. D., Eisenman, R. N., and Herr, W. (2003). Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are teth-ered together selectively by the cell-proliferation factor HCF-1. Genes Dev., 17, 896-911.
110. Xiao, H., Pearson, A., Coulombe, B. et al. (1994). Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell Biol., 14, 7013-7024.
111. Yan, G. Z. and Ziff, E. B. (1997). Nerve growth factor induces tran-scription of the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor. J. Neurosci., 17, 6122-6132.
112. Yudkovsky, N., Ranish, J. A., and Hahn, S. (2000). A transcription reinitiation intermediate that is stabilized by activator. Nature, 408, 225-229.
113. Zhao, H., Jin, S., Fan, F., Fan, W., Tong, T., and Zhan, Q. (2000). Activation of the transcription factor Oct-1 in response to DNA damage. CancerRes., 60, 6276-6280.
114. Zheng, L., Roeder, R. G., and Luo, Y. (2003). S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell, 114, 255-266.
115. Zwilling, S., Annweiler, A., and Wirth, T. (1994). The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP. Nucl. Acids Res., 22, 1655-1662.
116. Zwilling, S., Konig, H., and Wirth, T. (1995). High mobility group pro-tein 2 functionally interacts with the POU domains of octamer transcription factors. Embo J., 14, 1198-1208.